Denver, Colorado: Mirada Medical is introducing Registration AssuranceSM at the annual conference of the American Association of Physicists in Medicine (AAPM) to give clinicians total confidence in deformable registration as they integrate it into clinical practice. The AAPM conference is being held July 20-23 in Austin, Texas and attended by leading medical physicists from around the world. The conference includes a major focus on the increasing integration of advanced imaging technologies such as deformable image registration in the guidance of medical therapeutics.

One of the hottest topics at AAPM this year concerns the increasing growth of Deformable Image Registration (DIR) utilization in Radiation Oncology and the subsequent critical need to evaluate fusion accuracy.

In response, Mirada Medical is announcing Registration AssuranceSM, a comprehensive program for ensuring DIR quality and continuous improvement through rigorous scientific validation of technology, education, comprehensive QC tools and a commitment to ongoing development and support. Mirada recognizes that as medical physicists continue to discuss how to integrate deformable registration into their clinical workflow, they need to be sure that the technology they use can be trusted to provide the best quality of care to the patient.

"Through technology licensing and fusion products, Mirada Medical has been providing the community with high quality deformable image registration since 2002," stated Dr. Timor Kadir, Chief Technology Officer of Mirada Medical. "Registration AssuranceSM demonstrates our continued commitment to supporting the Radiation Oncology community in adopting and developing their use of this important technology."

Within the context of this program, Mirada Medical will be presenting a number of research papers focusing on the scientific validation of its technology including collaborative co-authors from Rush University (US), Duke University (US), Rigshospitalet (Copenhagen), and the Maastro Clinic (Netherlands). These include Evaluation of deformable registration for correcting respiratory motion in 4DCT lung images (SU-E-J-173 Sunday 3-6:00PM room: exhibit hall) which provides results of DIR accuracy on the publically available POPI dataset and The influence of rigid registration on the deformable registration quality in the context of atlas contouring (SU-F-BRF-5 Sunday 4-6:00PM room: ballroom F). In this paper Dr. Mark Gooding, Senior Scientist at Mirada Medical, will highlight the importance of using application specific approaches to DIR and an appropriate rigid initialization to assure the quality of deformable registration.

Mirada Medical will be demonstrating its complete suite of radiotherapy applications, and highlighting its unique Registration AssuranceSM program at AAPM, booth #137. The researchers will be available to discuss their research and answer questions.

For more information, please contact:

Mirada Medical
US/Worldwide: Robert Ripley
Tel: (440) 591-8638
Insource Communications
rripley@insourceinc.com
enquiries@mirada-medical.com
www.mirada-medical.com

U.S. Headquarters:

Mirada Medical USA, Inc.
999 18th Street
Suite 2025N
Denver, CO 80202
Tel: (303) 379-9228

World Headquarters:

Oxford Centre for Innovation
New Road, Oxford
OX1 1BY
United Kingdom
Tel: +44 (0) 1865 261410

About Mirada Medical Ltd

Mirada Medical is a leading international brand in medical imaging. The company develops advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada's products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere.

The company specializes in simplifying technically complex image processing tasks, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. Mirada's advanced software products are available throughout the world under its own brand, and on an OEM basis through a select number of the world's leading healthcare companies.

Mirada Medical was originally spun out of the University of Oxford. The company's technologies and products continue to be developed by their team of specialists, engineers and world-renowned scientists at Mirada's world headquarters in Oxford, England.

Mirada Medical, RTx, Casemeeting, Caseaccess and XD3 are all trademarks of Mirada Medical Ltd.